Serologic testing for zika virus: Comparison of three zika virus IgM screening enzyme-linked immunosorbent assays and initial laboratory experiences

Journal of Clinical Microbiology

Volumn 55, Issue 7, 2017, Pages 2127-2136

  Granger, Dane ^a   Hilgart, Heather ^a   Misner, Lori ^a   Christensen, Jaime ^b   Bistodeau, Sarah ^b   Palm, Jennifer ^b   Strain, Anna K ^b   Konstantinovski, Marja ^c   Liu, Dakai ^c   Tran, Anthony ^c   Theel, Elitza S ^a  

^a MAYO CLINIC   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

^c NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

Serology; Zika virus

Indexed keywords

IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; IMMUNOLOGIC FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL LABORATORY; CONTROLLED STUDY; DENGUE VIRUS; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIENCE; FEMALE; FLAVIVIRUS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEROLOGY; ZIKA FEVER; ZIKA VIRUS; BLOOD; COMPARATIVE STUDY; EVALUATION STUDY; IMMUNOLOGY; MIDDLE AGED; NEWBORN; PREGNANCY; PRESCHOOL CHILD; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTORS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREGNANCY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; YOUNG ADULT; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85021255353     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00580-17     Document Type: Article

References (28)

1. Campos GS, Bandeira AC, Sardi SI. 2015. Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis 21:1885-1886. https://doi.org/10.3201/eid2110.150847.
2. Waggoner JJ, Pinsky BA. 2016. Zika virus: diagnostics for an emerging pandemic threat. J Clin Microbiol 54:860-867. https://doi.org/10.1128/JCM.00279-16.
3. PAHO/WHO. 2016. Zika suspected and confirmed cases reported by countries and territories in the Americas: cumulative cases, 2015-2016. PAHO/WHO, Washington, DC.
4. Petersen LR, Jamieson DJ, Powers AM, Honein MA. 2016. Zika virus. N Engl J Med 374:1552-1563. https://doi.org/10.1056/NEJMra1602113.
5. D'Ortenzio E, Matheron S, Yazdanpanah Y, de Lamballerie X, Hubert B, Piorkowski G, Maquart M, Descamps D, Damond F, Leparc-Goffart I. 2016. Evidence of sexual transmission of Zika virus. N Engl J Med 374:2195-2198. https://doi.org/10.1056/NEJMc1604449.
6. Driggers RW, Ho CY, Korhonen EM, Kuivanen S, Jaaskelainen AJ, Smura T, Rosenberg A, Hill DA, DeBiasi RL, Vezina G, Timofeev J, Rodriguez FJ, Levanov L, Razak J, Iyengar P, Hennenfent A, Kennedy R, Lanciotti R, du Plessis A, Vapalahti O. 2016. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med 374:2142-2151. https://doi.org/10.1056/NEJMoa1601824.
7. Musso D, Nhan T, Robin E, Roche C, Bierlaire D, Zisou K, Shan Yan A, Cao-Lormeau VM, Broult J. 2014. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill 19(14):pii-20761. http://www.eurosurveillance.org/ViewArticle.aspx ?ArticleId-20761.
8. Silveira FP, Campos SV. 2016. The Zika epidemics and transplantation. J Heart Lung Transplant 35:560-563. https://doi.org/10.1016/j.healun.2016.03.010.
9. Swaminathan S, Schlaberg R, Lewis J, Hanson KE, Couturier MR. 2016. Fatal Zika virus infection with secondary nonsexual transmission. N Engl J Med 375:1907-1909. https://doi.org/10.1056/NEJMc1610613.
10. Calvet GA, Santos FB, Sequeira PC. 2016. Zika virus infection: epidemiology, clinical manifestations and diagnosis. Curr Opin Infect Dis 29: 459-466. https://doi.org/10.1097/QCO.0000000000000301.
11. Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, Vial AL, Decam C, Choumet V, Halstead SK, Willison HJ, Musset L, Manuguerra JC, Despres P, Fournier E, Mallet HP, Musso D, Fontanet A, Neil J, Ghawche F. 2016. Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: A case-control study. Lancet 387:1531-1539. https://doi.org/10.1016/S0140-6736(16)00562-6.
12. Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. 2016. Zika virus and birth defects-reviewing the evidence for causality. N Engl J Med 374:1981-1987. https://doi.org/10.1056/NEJMsr1604338.
13. WHO. 2016. Fifth meeting of the Emergency Committee under the International Health Regulations (2005) regarding microcephaly, other neurological disorders and Zika virus. WHO, Geneva, Switzerland. http://www.who.int/mediacentre/news/statements/2016/zika-fifth-ec/en/. Accessed 10 February 2017.
14. Oduyebo T, Igbinosa I, Petersen EE, Polen KN, Pillai SK, Ailes EC, Villanueva JM, Newsome K, Fischer M, Gupta PM, Powers AM, Lampe M, Hills S, Arnold KE, Rose LE, Shapiro-Mendoza CK, Beard CB, Muñoz JL, Rao CY, Meaney-Delman D, Jamieson DJ, Honein MA. 2016. Update: interim guidance for health care providers caring for pregnant women with possible Zika virus exposure-United States, July 2016. MMWR Morb Mortal Wkly Rep 65:739-744. https://doi.org/10.15585/mmwr.mm6529e1.
15. WHO. 2016. Laboratory testing for Zika virus infection-Interim guidance. WHO, Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/204671/1/WHO-ZIKV-LAB-16.1-eng.pdf?ua-1.
16. Landry ML, St George K. 2017. Laboratory diagnosis of Zika virus infection. Arch Pathol Lab Med 141:60-67. https://doi.org/10.5858/arpa.2016-0406-SA.
17. MMWR. 2016. Announcement: guidance for U.S. laboratory testing for Zika virus infection: implications for health care providers. MMWR Morb Mortal Wkly Rep 65:1304. https://doi.org/10.15585/mmwr.mm6546a7.
18. FDA. 2016. Zika virus emergency use authorization. FDA, Washington, DC. https://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm. Accessed 7 February 2017.
19. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, Stanfield SM, Duffy MR. 2008. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14:1232-1239. https://doi.org/10.3201/eid1408.080287.
20. Steinhagen K, Probst C, Radzimski C, Schmidt-Chanasit J, Emmerich P, van Esbroeck M, Schinkel J, Grobusch MP, Goorhuis A, Warnecke JM, Lattwein E, Komorowski L, Deerberg A, Saschenbrecker S, Stocker W, Schlumberger W. 2016. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: A multicohort study of assay performance, 2015 to 2016. Euro Surveill 21(50):pii-30426. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId-22670.
21. Huzly D, Hanselmann I, Schmidt-Chanasit J, Panning M. 2016. High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses. Euro Surveill 21(16):pii-30203. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId-21450.
22. Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, Vanzetta F, Minola A, Jaconi S, Mele F, Foglierini M, Pedotti M, Simonelli L, Dowall S, Atkinson B, Percivalle E, Simmons CP, Varani L, Blum J, Baldanti F, Cameroni E, Hewson R, Harris E, Lanzavecchia A, Sallusto F, Corti D. 2016. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353:823-826. https://doi.org/10.1126/science.aaf8505.
23. Song H, Qi J, Haywood J, Shi Y, Gao GF. 2016. Zika virus NS1 structure reveals diversity of electrostatic surfaces among flaviviruses. Nat Struct Mol Biol 23:456-458. https://doi.org/10.1038/nsmb.3213.
24. Speer SD, Pierson TC. 2016. Virology. Diagnostics for Zika virus on the horizon. Science 353:750-751.
25. FDA. 2017. FDA warns health care providers against relying solely on Zika virus serological IgM assay results; reminds them to wait for confirmatory test results before making patient management decisions: FDA safety communication. FDA, Washington, DC. https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm534515.htm. Accessed 30 January 2017.
26. InBios. 2017. ZIKV Detect IgM capture ELISA instructions for use. InBios International, Inc., Seattle, WA. https://www.fda.gov/downloads/Medical Devices/Safety/EmergencySituations/UCM517147.pdf.
27. CDC. 2016. Zika MAC-ELISA instructions for use. CDC, Atlanta, GA. https://www.fda.gov/downloads/MedicalDevices/Safety/Emergency Situations/UCM488044.pdf.
28. Fleiss JL, Levin B, Paik MC. 2003. Statistical methods for rates and proportions. Wiley-Interscience, Hoboken, NJ.